Results 111 to 120 of about 5,892 (166)

A hidden nonfunctioning kidney in autosomal dominant polycystic kidney disease. [PDF]

Kidney Res Clin Pract
Jung Y, Kim YN, Shin HS, Rim H.
europepmc   +1 more source

Real-World Effectiveness of Tolvaptan for Hyponatremia in Cirrhosis Across Global Regions: A Target Trial Emulation. [PDF]

JGH Open
Okushin K, Tateishi R, Fujishiro M, Tsutsumi T, Koike K, Tanaka T.   +5 more
europepmc   +1 more source

Paradoxical Hyponatremia on High-Dose Tolvaptan in ADPKD. [PDF]

Kidney Int Rep
De Rosa LI, Bianca P, Catania M, Kola K, Paolisi M, Brambilla Pisoni M, Farinone S, Maiucchi P, Citterio L, Petrone M, Rivera RF, Manunta P, Lanzani CL, Vezzoli G, Sciarrone Alibrandi MT.   +14 more
europepmc   +1 more source

Mid-Term Impact of Kampo Goreisan in Patients with Congestive Heart Failure Receiving Tolvaptan-Incorporated Medical Therapy. [PDF]

J Clin Med
Hida Y, Imamura T, Kinugawa K.
europepmc   +1 more source

Efficacy and safety of tolvaptan in rapidly progressing autosomal dominant polycystic kidney disease: a single-center, prospective, single-arm study. [PDF]

Transl Androl Urol
Zhou L, Li W.
europepmc   +1 more source

In Reply: Pseudo-Index Events cannot be Configured on the TriNetX Platform. [PDF]

Mayo Clin Proc Innov Qual Outcomes
Wu TK.
europepmc   +1 more source

Evidence for a tubular basement membrane-cilia connection in autosomal dominant polycystic kidney disease pathogenesis. [PDF]

J Clin Invest
Sussman CR, Harris PC.
europepmc   +1 more source

Diffusion MRI Radiomics Predict Renal Function Decline in ADPKD. [PDF]

Kidney Int Rep
Bargagli M, Altabella L, Fedon Vocaturo M, Negrelli R, Ambrosetti MC, Puppini G, Cavedon C, Scoglio M, Fuster DG, Ferraro PM.   +9 more
europepmc   +1 more source

Effect of tolvaptan on the prognosis of patients with rapidly progressive autosomal dominant polycystic kidney disease: a prospective open-label study. [PDF]

Front Med (Lausanne)
Zhou L, Li W.
europepmc   +1 more source

Treatment of Autosomal Dominant Polycystic Kidney Disease: Integrating Clinical Practice Guidelines, Patient Perspectives, and Real-World Effectiveness. [PDF]

J Am Soc Nephrol
Rangan G.
europepmc   +1 more source